Suppressive effects of novel ferulic acid derivatives on cellular responses induced by phorbol ester, and by combined lipopolysaccharide and interferon-γ

Cancer Letters

Volumn 157, Issue 1, 2000, Pages 77-85

  Murakami, Akira ^a   Kadota, Megumi ^a   Takahashi, Daisuke ^a   Taniguchi, Hisaji ^b   Nomura, Eisaku ^b   Hosoda, Asao ^b   Tsuno, Takuo ^c   Maruta, Yuko ^c   Ohigashi, Hajime ^d   Koshimizu, Koichi ^a  

^a Fac Biol Oriented Sci T   (Japan)

^b INDUSTRIAL TECHNOLOGY CENTER OF WAKAYAMA PREFECTURE   (Japan)

^c Tsuno Food Industrial Co Ltd   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Chemoprevention; Cyclooxygenase 2; Epstein Barr virus; Inducible nitric oxide synthase; Superoxide anion

Indexed keywords

CYCLOOXYGENASE 2; FERULIC ACID; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; PHENOL DERIVATIVE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HL 60; CHEMOPROPHYLAXIS; CYTOTOXICITY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAJI CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; CELL LINE; COUMARIC ACIDS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DRUG INTERACTIONS; ENZYME INDUCTION; HERPESVIRUS 4, HUMAN; HL-60 CELLS; HUMANS; INTERFERON TYPE II; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 0034739324     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00478-X     Document Type: Article

References (23)

1. Suh N., Honda T., Finlay H.J., Barchowsky A., Williams C., Benoit N.E., Xie Q.W., Nathan C., Gribble G.W., Sporn M.B. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Res. 58:1998;717-723.
2. Futakuchi M., Hirose M., Miki T., Tanaka H., Ozaki M., Shirai T. Inhibition of DMBA-initiated rat mammary tumour development by 1-O-hexyl-2,3,5-trimethylhydroquinone, phenylethyl isothiocyanate, and novel synthetic ascorbic acid derivatives. Eur. J. Cancer Prev. 7:1998;153-159.
3. Lin J.K., Liang Y.C., Lin-Shiau S.Y. chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58:1999;911-915.
4. Yang C.S., Yang G.Y., Landau J.M., Kim S., Liao J. Tea and tea polyphenols inhibit cell hyperproliferation, lung tumorigenesis, and tumor progression. Exp. Lung Res. 24:1998;629-639.
5. Taniguchi H., Hosoda A., Tsuno T., Maruta Y., Nomura E. Preparation of ferulic acid and its application for the synthesis of cancer chemopreventive agents. Anticancer Res. 19:(5A):1999;3757-3761.
6. Wattenberg L.W., Coccia J.B., Lam L.K. Inhibitory effects of phenolic compounds on benzo(a)pyrene-induced neoplasia. Cancer Res. 40:(8 Pt1):1980;2820-2823.
7. Lesca P. Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-induced neoplasia in mice. Carcinogenesis. 4:1983;1651-1653.
8. Huang M.T., Smart R.C., Wong C.Q., Conney A.H. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate, Cancer Res. 48:1988;5941-5946.
9. Kaul A., Khanduja K.L. Polyphenols inhibit promotional phase of tumorigenesis: relevance of superoxide radicals. Nutr. Cancer. 32:1998;81-85.
10. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis. 14:1993;1321-1325.
11. Mori H., Kawabata K., Yoshimi N., Tanaka T., Murakami T., Okada T., Murai H. Chemopreventive effects of ferulic acid on oral and rice germ on large bowel carcinogenesis. Anticancer Res. 19:(5A):1999;3775-3778.
12. Hirose M., Takahashi S., Ogawa K., Futakuchi M., Shirai T., Shibutani M., Uneyama C., Toyoda K., Iwata H. Chemoprevention of heterocyclic amine-induced carcinogenesis by phenolic compounds in rats. Cancer Lett. 143:1999;173-178.
13. Murakami A., Gao G., Kim O.-K., Omura M., Yano M., Ito C., Furukawa H., Jiwajinda S., Koshimizu K., Ohigashi H. Identification of coumarins from the fruit of Citrus hystrix DC as inhibitors of nitric oxide generation in mouse macrophage RAW 264.7 cells. J. Agric. Food Chem. 47:1999;333-339.
14. Murakami A., Ohigashi H., Koshimizu K. Chemoprevention: insights into biological mechanisms and promising food factors. Food Rev. Int. 15:1999;335-395.
15. Murakami A., Manaf A., Kamaruddin A., Koshimizu M.-S.K., Ohigashi H. Screening for in vitro anti-tumor-promoting activities of edible plants from Malaysia. Biosci. Biotechnol. Biochem. 64:2000;9-16.
16. Nakamura Y., Ohto Y., Murakami A., Ohigashi H. Superoxide scavenging activity of rosmarinic acid from Perilla frutescens Britton var. acuta f. viridis. J. Agric. Food Chem. 46:1998;4545-4550.
17. Kim O.-K., Murakami A., Nakamura Y., Ohigashi H. Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 264.7 cells. Cancer Lett. 125:1998;199-207.
18. Tsuda H., Park C.B., Takasuka N., Baba-Toriyama H., Sekine K., Moore M.A., Nomura E., Taniguchi H. Influence of ethyl 3-(4′-geranyloxy-3′-methoxyphenyl)-2-propenoate (EGMP) on early stage colon carcinogenesis in rats treated with azoxymethane (AOM). Anticancer Res. 19:(5A):1999;3779-3782.
19. J.R. Johnson, The Perkin reaction and related reactions, in: R. Adams (Ed.), Organic Reactions, New York, Wiley, 1942, pp. 210-265.
20. El-Bayoumy K., Iatropoulos M., Amin S., Hoffman D., Wynder E.L. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tabacco-specific nitrosoamine 4-(methylnitrosoamino)-4-(3-pyridyl)-1-butanone: the impact of a high-fat diet. Cancer Res. 59:1999;1400-1403.
21. Goto T., Haruma K., Kitadai Y., Ito M., Yoshihara M., Sumii K., Hayakawa N., Kajiyama G. Enhanced expression of inducible nitric oxide synthase and nitrotyrosine in gastric mucosa of gastric cancer patients. Clin. Cancer. Res. 5:1999;1411-1415.
22. Rao C.V., Kawamori T., Hamid R., Reddy B.S. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis. 20:1999;641-644.
23. Singh J., Hamid R., Reddy B.S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57:1997;3465-3470.